A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines

Completed · Phase 1

Conditions studied: HIV Infections

In brief

The purpose of this study is to see if it is safe and effective to give AIDSVAX B/B or AIDSVAX B/E, two potential HIV vaccines, to HIV-negative volunteers.

Key facts

Study ID

NCT00002402

Run by

VaxGen

People needed

120

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Dr Frank Judson / Director of Public Health Dept — Denver, Colorado, United States
• Johns Hopkins Bloomberg School of Public Health — Washington D.C., District of Columbia, United States
• Fenway Community Health Ctr — Boston, Massachusetts, United States
• Saint Louis Univ Health Sciences Ctr — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.